MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells

Figure 2

RNA sequencing analysis in DC-CIK cells from normal and AML patients. (a) After RNA sequencing, the principal component analysis was utilized to display the classification of expression profile data between the DC-CIK cells from normal and AML patients. The colors represent groups, and the -axis represents a principal component. (b) The expressions of mRNAs were exhibited using a scatter diagram. (c) Heat map was also used to display the differentially expressed mRNAs in the DC-CIK cells from normal and AML patients. (d) Volcano plot was also adopted to represent the upregulated (red dots), not differentially expressed (black dots), and downregulated (green dots) mRNAs.

(a)

(b)

(c)

(d)